​

Funding Round

Post-IPO Debt - Abivax

Post-IPO Debt - Abivax

Investment Firm

Overview

Abivax develops medicines that alter the body's natural immune system mechanisms.

Announced Date

Aug 21, 2023

Funding Type

Post Ipo Debt

Highlights

Location

Europe

Social

Investor Lead

Kreos Capital

Kreos Capital

Kreos Capital is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Heights Capital Management

Heights Capital Management

Heights Capital Management is a late_stage_venture and private_equity firm.

Participant Investors

2

Investor Name
Participant InvestorHeights Capital Management
Participant InvestorKreos Capital

Round Details and Background

Abivax raised $163465824 on 2023-08-21 in Post-IPO Debt

Abivax develops medicines that alter the body's natural immune system mechanisms.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 13, 2020
Post-IPO Debt - Abivax
1-17.6M
Sep 02, 2022
Post-IPO Equity - Abivax
6-49.0M
Feb 22, 2023
Post-IPO Equity - Abivax
10-137.9M
Aug 21, 2023
Post-IPO Debt - Abivax
3-163.5M

Recent Activity

There is no recent news or activity for this profile.